Schedule 13G ownership disclosure

Protagonist Therapeutics Inc

Security class unavailable · CUSIP: 74366E102

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000908834-24-000035
Form type
SC 13G/A
Filer
Farallon Capital Partners, L.P.
CIK
CIK 1175707
Filed
Feb 02, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub